Nicholas James Gordon McVie REFERENCE: Abstract: 3LB (Presidential Session), ECCO 14, The European Cancer Conference, Barcelona, 23 – 27...
Jose Baselga Gordon McVie REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JOSE BASELGA...
Pierre Guillou David Jayne REFERENCE: J Clin Oncol 25:3061-3068 PIERRE GUILLOU, St James’ Hospital, Leeds COMMENT: DAVID JAYNE, St James’...
Rachel Johnson Terry Mamounas William Gradishar Withhold Trastuzumab in Low-Risk Patients with HER-2 Positive Breast Cancer? REFERENCE: Abstract:...
IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for...
Dennis Slamon George Peoples James Holland Massimo Christofanilli Trastuzumab: Mature Results in Early Breast Cancer Show Superiority REFERENCE: San...
Clifford Hudis Mark Einstein Tony Greco James Berenson Edward Ambinder Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance...
David Cameron Martine Piccart Eric Van Cutsem Jim Cassidy Volker Heinemann Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre...
Gordon McVie Martine Piccart Bella Kaufman Jean-Yves Douillard ESMO Congress Reviewed GORDON MCVIE, European Institute of Oncology, Milan In...
AudioMedica News Audio Journal of Oncology in Advance - October 1st, 2006 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast...
AudioMedica News ASCO Audio Journal of Oncology - September 15th, 2006 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast...
AudioMedica News ASCO Audio Journal of Oncology - August 15th 2006 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward...